Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.

J Neuropathol Exp Neurol 2009 Nov;68(11):1219-28

Department of Neurosurgery, Ludwig-Maximilians University, Munich, Germany.

We report a molecular stereotactic biopsy technique that combines histopathologic diagnosis with small sample size-adjusted molecular genetic analysis of low-grade gliomas that are ineligible for tumor resection. Loss of heterozygosity (LOH) of 1p/19q and TP53 mutations were analyzed in 1-mm tissue samples from 42 World Health Organization grade II gliomas (30 astrocytomas, 8 oligoastrocytomas, 4 oligodendrogliomas) using polymerase chain reaction-based microsatellite and sequence analysis. Alternating histological and molecular genetic evaluation within 1-mm steps at different sites within each tumor was performed to determine reproducibility of the results and the intratumoral distribution of the biomarkers. Multiple serial biopsies (range, 2-5 per tumor) taken from distinct intratumoral areas revealed concordant molecular genetic findings and homogeneous distribution of both biomarkers throughout 41 tumors. Contamination by nonneoplastic tissue could be recognized by corresponding histological evaluation and resulted in discordant LOH findings in 1 tumor. The frequency of LOH 1p/19q and TP53 mutations was consistent with the literature; these genetic alterations were found to be mutually exclusive. There was no biopsy-related morbidity. We conclude that determination of the LOH 1p/19q and TP53 status using this molecular stereotactic biopsy technique is safe and reliable in cases of unresectable gliomas.

Download full-text PDF

Source
http://jnen.oxfordjournals.org/content/jnen/68/11/1219.full.
Web Search
http://jnen.oxfordjournals.org/cgi/doi/10.1097/NEN.0b013e318
Publisher Site
http://dx.doi.org/10.1097/NEN.0b013e3181bee1f1DOI Listing
November 2009
22 Reads

Publication Analysis

Top Keywords

1p/19q tp53
16
stereotactic biopsy
12
molecular genetic
12
molecular stereotactic
12
loh 1p/19q
12
tp53 mutations
12
grade gliomas
8
loss heterozygosity
8
biopsy technique
8
distribution biomarkers
8
organization grade
8
health organization
8
molecular
5
serial biopsies
4
biomarkers multiple
4
multiple serial
4
range 2-5
4
areas revealed
4
revealed concordant
4
concordant molecular
4

References

(Supplied by CrossRef)

Kreth et al.
Cancer 1997

Kreth et al.
Cancer 2006

Okamoto et al.
Acta Neuropathol 2004

Cairncross et al.
J Clin Oncol 2006

Cairncross et al.
Cancer J 2008

Stander et al.
Cancer 2004

Grasbon-Frodl et al.
Int J Cancer 2007

Kreth et al.
Acta Neurochir (Wien) 2001

Louis et al.
Acta Neuropathol 2007

Van Gelder et al.
Proc Natl Acad Sci U S A 1990

Esteban et al.
J Biol Chem 1993

Similar Publications